Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
- Type
- Retraction
- Notice date
- 12/7/2023 0:00
- Journal
- Frontiers in Oncology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fonc.2023.1337635
- Original paper DOI
- 10.3389/fonc.2020.588533
Reasons
- Error in Data
- Investigation by Journal/Publisher
- Results Not Reproducible
- Unreliable Results and/or Conclusions
- Upgrade/Update of Prior Notice(s)